Bukwang Pharmaceutical Co., Ltd. (KRX:003000)

Bukwang Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	350,260	314,207	417,573	598,978	883,065	1,924,170
Market Cap Growth	-31.14%	-24.75%	-30.29%	-32.17%	-54.11%	109.52%
Enterprise Value	291,345	280,401	368,683	519,044	826,852	1,868,498
Last Close Price	3550.00	4250.57	5648.90	8102.94	11946.05	25825.61
PE Ratio	29.20	-	-	-	-	-
Forward PE	-	58.75	58.75	58.75	58.75	58.75
PS Ratio	1.95	1.96	3.32	3.14	4.84	11.34
PB Ratio	1.40	1.29	1.78	2.20	3.15	7.10
P/TBV Ratio	1.45	1.32	1.93	2.34	3.36	7.65
P/FCF Ratio	10.68	9.69	-	49.25	34.31	-
P/OCF Ratio	9.25	9.14	-	36.39	33.29	2660.75
EV/Sales Ratio	1.63	1.75	2.93	2.72	4.53	11.01
EV/EBITDA Ratio	20.07	48.99	-	106.23	79.01	183.44
EV/EBIT Ratio	29.75	173.34	-	-	147.08	463.86
EV/FCF Ratio	8.88	8.65	-	42.67	32.12	-
Debt / Equity Ratio	0.32	0.33	0.34	0.00	0.01	0.08
Debt / EBITDA Ratio	5.39	13.88	-	0.19	0.15	2.12
Debt / FCF Ratio	2.45	2.45	-	0.08	0.06	-
Asset Turnover	0.49	0.40	0.30	0.48	0.46	0.43
Inventory Turnover	1.98	1.75	1.66	2.87	2.36	2.06
Quick Ratio	4.30	4.37	1.93	3.90	4.79	3.16
Current Ratio	5.77	5.76	2.61	4.90	5.95	4.06
Return on Equity (ROE)	3.41%	-1.45%	-13.60%	-1.54%	-1.01%	-3.38%
Return on Assets (ROA)	1.73%	0.25%	-5.65%	-0.04%	0.88%	0.64%
Return on Capital (ROIC)	1.98%	0.32%	-7.99%	-0.05%	1.22%	0.81%
Return on Capital Employed (ROCE)	2.90%	0.50%	-	-	1.60%	1.20%
Earnings Yield	2.39%	-0.84%	-7.50%	-0.41%	-0.10%	-0.37%
FCF Yield	9.37%	10.32%	-2.92%	2.03%	2.92%	-0.06%
Buyback Yield / Dilution	-0.13%	-	-	0.01%	0.25%	4.24%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.